Jordi Mas

Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona operates as a banking foundation. It offers retail banking services such as savings accounts, deposits, pension, and insurance, as well as private banking and financial advisory, including personalized investment strategies and portfolio management. The company was founded in 1904 and is headquartered in Barcelona, Spain.

BBVA Asset Management SA SGIIC (BBVA-AM) is the asset management subsidiary of Banco Bilbao Vizcaya Argentaria SA (BME: BBVA, ADR: BBVA) in Spain. Founded in 1979 as BBV Gestinova, the firm became BBVA Gestión in 2000 when BBV Gestinova and Argentaria Gestión merged and was rebranded as BBVA-AM in 2008. They are headquartered in Madrid and manage pension plans and participate in the Latin American markets of Mexico, Colombia, Ecuador, Peru, Bolivia, Chile and Argentina. BBVA-AM also manages a range of investment mandates for insurance companies, employment plans and corporate clients through their platform in Luxembourg.

Abanca Gestion de Activos SGIIC SA is the wholly owned investment management subsidiary of Abanca Group Corporación Bancaria SA in Spain. The firm was founded in 1990 as Gesinca Inversiónes, changed their name to Ahorro Corporacion Gestion in 2000 and subsequently became Imantia Capital SGIIC SA (Imantia Capital) in 2016. In 2023, Imantia Capital and Bankoa Gestión, merged into a single firm, Abanca Gestión de Activos SGIIC SA. Headquartered in Madrid, the firm manages a range of mutual funds for individual and institutional investors.

VidaCaixa SAU de Seguros y Reaseguros is an insurance management firm headquartered in Barcelona, Spain. The firm was founded in 1987 and they are a subsidiary of CaixaBank SA (BME: CABK). VidaCaixa provides investment advice for insurance company portfolio.

Bankinter Gestión de Activos SA SGIIC (BGA) is the wholly-owned asset management subsidiary of Bankinter SA (BME: BKT; ADR: BKNIY) in Spain. Headquartered in Madrid, the firm was founded in 1986 and provides fund management services to private and institutional clients.

Trea Asset Management SGIIC SA (Trea AM) is the asset management subsidiary of Team & Work 5000 SL in Spain. Recently known as Nobangest SGIIC SA, the firm was founded in 1989 and formerly known as Novo Banco Gestión SGIIC SA and prior to that Espírito Santo Gestión SGIIC SA. Headquartered in Madrid, Trea AM manages funds for institutional and private investors.

CaixaBank SA (Private Banking) is the private banking division of CaixaBank SA (MP: CABK) in Spain. La Caixa was created in 1990 when Caja de Pensiones para la Vejez y de Ahorros de Cataluña y Baleares, founded in 1904, and the Caja de Ahorros y Monte de Piedad de Barcelona, founded in 1844, merged. The firm is headquartered in Barcelona and provides a range of private banking services for high-net worth clients.

Dooria AS manufactures wooden doors. The firm offers a product range that covers various needs in design and function: interior doors, exterior doors, and classed doors. It mainly sells its products through major building chains, as well as directly to large contractors, house manufacturers, public and private builders. It also sells knob, lock, canopy, and hardware. The company was founded in 1947 and is headquartered in Oslo, Norway.

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

Inveready Asset Management SGEIC SA (Inveready) is a private equity and venture capital subsidiary of Inveready Capital Co. SL founded in 2008 by Joseph Maria Echarri Torres. The firm is headquartered in San Sebastian, Spain.

Caixa Capital Risc SGEIC SA (Caixa Capital Risc) is a venture capital armof Criteria Caixa SA founded in 2002. The firm is headquartered in Barcelona, Spain with additional offices in Madrid.

Santander Asset Management SA SGIIC (Santander AM) is the asset management subsidiary of Santander Asset Management Investment Holdings Ltd. in Great Britain, itself a subsidiary of Banco Santander SA (BME: SAN) in Spain. Founded in 1971, the firm is headquartered in Madrid and has a network of offices throughout Spain and local investment teams throughout the world. Santander AM manages a volume of assets for both individual and institutional clients, as well as for Santander Group subsidiaries in all geographies.

Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain.

Agrasys SL develops and commercialize crops and cereals. It offers Tritordeum, a non genetic modification cereals and developed for human nutrition. The company was founded in 2005 and is headquartered in Barcelona, Spain.

ADman Interactive SL provides video streaming platform. It offers video distribution for instream, out stream and native video. Its products include Intext, In-Banner, I-Spot, and native video. The company was founded by Josep Maria Tribó Capdevila, Marcos David Luengo Sánchez and Victor Sala Gracia in 2010 and is headquartered in Barcelona, Spain.

Ability Pharmaceuticals SL operates as a clinical stage drug discovery and development biopharmaceutical firm. It develops human therapeutics to treat cancer and other indications with unmet medical needs. The company was founded by Carles Domènech Garcia Jordi Espadaler Mazo in November 2009 and is headquartered in Barcelona, Spain.

Julius Baer Gestión SGIIC SA (JBS) is the wealth management subsidiary of Julius Baer Gruppe AG (SWX: BAER). The firm is headquartered in Madrid and was founded in 2010. JBS provides investment advisory and wealth management services to their clients.

Part of Norvestor Equity AS, Cegal Group AS is a provider of hybrid cloud solutions, software and consulting services in IT, business, geoscience and data management. The company is based in Sandnes, Norway. The Norwegian company was founded in 2010. Dagfinn Ringås has been the CEO of the company since 2020.

Zera Intein Protein Solutions SL develops and commercializes biomedical technologies, with applications in the biotechnological, pharmaceutical, veterinary and industrial sectors. Its proprietary technologies include Zera and Splittera. Zera technology is composed of self-assembler peptides for DNA vaccines, carrier-free enzyme immobilization, and biopharmaceutical protein production. Splittera refers to Split Intein technology which includes trans-splicing, cyclization, and cleavage reactions. The company was founded on January 30, 2015 and is headquartered in Barcelona, Spain.

InnoUp Farma SL develops nanotechnology-based solutions for the administration of oral drugs. It offers anti-cancer drugs with low oral bioavailability. The company was founded by Maite Agueros Bazo, Manuel Rodriguez Mariscal and Juan Manuel Irache Garreta and is headquartered in Noain, Spain.

Avizorex Pharma SL develops drugs for the treatment of the dry eye disease. The company was founded by Carlos Belmonte and Sauri Patrick Tresserras in July, 2013 and is headquartered in Barcelona, Spain.

Part of Sinergia Global Partners SL, Wealth Solutions EAFI SL is a Spanish company that provides wealth management advisory services. The company is based in Madrid, Spain. Francisco de Borja Durán Carredano has been the CEO of the company since 2009.

Lanai Partners SL (Lanai Partners) is a venture capital firm founded in 2016 by Jeroen Merchiers, Rubén Ferreiro, Guillermo Llibre and Mar Alarcón The firm is headquartered in Barcelona, Spain.

AptaTargets SL is a biopharmaceutical company based in Madrid, Spain that focuses on developing therapeutic applications based on aptamer technology. The Spanish company is currently developing aptoll, an immune modulator that blocks the activation of tlr4 in a stroke, representing a novel approach to treat ischemic stroke in the acute phase. It could also be administered in patients up to 48 hours after the stroke. AptaTargets targets indications where inflammation causes significant damage through clinical studies and successful preclinical development. The company was founded in 2014 by David Segarra and María Eugenia Zarabozo, with David Segarra serving as the CEO since then.

Nectria SL develops software solutions for optimizing fleet management. It combines a strong multidisciplinary skillset with extensive expertise in logistics, AI, software engineering and business management. The company was founded by Mikael Baron, Oriol Serra, David Vega Costa, Miguel Valls Figueras, Victor Tejedo Palmero, Guillem Ricarte and Javier Juncadella in 2012 and is headquartered in Barcelona, Spain.

Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain.

PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA.

AmacaThera, Inc. is biotechnology company, which engages in the development and commercialization of injectable hydrogel platform technology. Its platform addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. The company was founded by Molly S. Soichet and Mike Cooke and is headquartered in Toronto, Canada.

Lutris Pharma Ltd. is working on the improvement of the anti-cancer therapy effectiveness and the quality of life for patients that are treated with Epidermal Growth Factor Receptor Inhibitors. The company was founded on December 14, 2015 and is headquartered in Tel Aviv, Israel.

Oxolife SL operates as an biotech company focused on treating female infertility. The company was founded by Agn?s Arbat and Ignasi Canals in 2013 and is headquartered in Barcelona, Spain.

Connecta Therapeutics SL is an innovation-oriented, R&D-intensive organization committed to developing innovative treatments for patients. Connecta Therapeutics is based in Barcelona, ES. The Spanish company strongly believes in improving the lives of patients and their families and understands the importance of teamwork and collaboration to achieve their goals. The company was founded in 2019 by Josep Prous, David Prous, and Jordi Fàbrega. Jordi Fàbrega has been the CEO since 2019.

Part of Immpact Bio USA, Inc., Kalthera, Inc. provides progressive clinical trials services. The company is based in Westlake Village, CA. The company was founded by Yvonne Chen, Cristina Puig Saus, Jim Johnston, Antoni Ribas. Jim Johnston has been the CEO since incorporation. Kalthera was acquired by Immpact Bio USA, Inc. on July 22, 2021.

Aimbot AS provides investment services. The private company is based in Oslo, Norway. and has subsidiaries in Norway. The Norwegian company was founded in 2021. The CEO is Odd Nymark.

Antalgenics SL is a Spanish biotechnological company that specializes in discovering and developing new bioactive molecules for biomedical and dermocosmetic applications. The company is based in Alicante, Spain. The company offers customized R & D services to design and develop projects according to the client's needs. The company's focus is on developing novel therapeutic leads, primarily for the treatment of psoriatic pruritus and psoriatic comorbidities. Antalgenics was founded in 2015, and the CEO is Philipp Tsolakis.